ErikaF(Fullwood)AugustineMD

Child Neurology • Baltimore, MD

Associate Chief Science Officer Director, Clinical Trials Unit Kennedy Krieger Institute

Join to view full profile

Dr. Augustine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Augustine's full profile

Already have an account?

Office
1741 Ashland Ave
Baltimore, MD 21205
Phone+1 585-275-0800

Fax+1 585-244-2529

Education & Training

Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Child Neurology, 2005 - 2008
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2003 - 2005
University of Rochester School of Medicine and DentistryClass of 2003

Certifications & Licensure

MD State Medical License 2020 - 2026
NY State Medical License 2008 - 2026
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Clinical Trials

Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis Start of enrollment: 2011 Jul 01
Completed
Phase 2
Clinical Trial Readiness for SCA1 and SCA3 Start of enrollment: 2018 Aug 16
Active, not recruiting

Publications & Presentations

PubMed

Coprophenomena Associated With Worse Individual and Family Function for Youth With Tourette Syndrome: A Cross-Sectional Study.
Samantha P Myers, Kathleen D Meeks, Heather Adams, Amy E Vierhile, Erika Augustine
Neurology. Clinical Practice. 2025-02-01
A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases.
Olivia Kim-McManus, Joseph G Gleeson, Laurence Mignon, Amena Smith Fine, Winston Yan
Nature Communications. 2024-11-12
N-of-1 Studies in an Era of Precision Medicine.
Erika F Augustine, Timothy W Yu, Richard S Finkel
JAMA. 2024-09-25

Press Mentions

URMC to Lead First Gene Therapy Study for Batten DiseaseNovember 3rd, 2021
New Grants Will Accelerate Clinical Trials in Rare Neurological DisordersJune 26th, 2019
UR Named National Center of Excellence for Parkinson’s ResearchOctober 3rd, 2018
Join now to see all